Alcohol use disorder: what blood tests can show
Clinical review pending
GGT, AST/ALT and MCV can reveal physical effects of alcohol. What the values mean, what affects them and why they cannot provide a diagnosis on their own.
What traces alcohol use can leave in the blood
Biomarkers for alcohol use disorder are measurable signals in the blood that shed light on how much alcohol has been consumed, how recently, and how the organs are responding. They complement what people report about their own drinking and can help put risky drinking, its pattern over time, strain on the liver and recovery into context. Some markers arise directly from alcohol itself, forming when alcohol binds to fats in the membranes of red blood cells (phosphatidylethanol, PEth). Others are byproducts of alcohol metabolism that can be detected within shorter time windows (ethyl glucuronide, EtG; ethyl sulfate, EtS). A second group reflects the body’s response to sustained drinking, such as changes in a liver transport protein (carbohydrate-deficient transferrin, CDT), rises in liver enzymes (gamma-glutamyl transferase, GGT; aspartate aminotransferase, AST; alanine aminotransferase, ALT) and enlarged red blood cells (mean corpuscular volume, MCV). Together, these tests can support diagnosis, make physical consequences visible, and help tailor treatment or assess abstinence and relapse over time.
Why GGT, AST/ALT and MCV matter together
Alcohol use disorder can show up in blood values: for example, through enzymes released from stressed liver cells, or through a change in the size of red blood cells as a result of effects on the bone marrow and nutrient supply. Together, these biomarkers show how alcohol affects liver metabolism, inflammation and blood cell formation, and with them energy, cognition and metabolic balance. The source gives typical reference ranges of about 10–40 for GGT, about 10–40 for AST, about 7–56 for ALT and about 80–100 for MCV, but states no units. These figures therefore cannot be used as complete laboratory references. The source considers GGT and AST/ALT in the low to middle part of the reference range, and MCV near its middle, to be favorable. Values within the reference range are interpreted here as signs of intact liver cell membranes, little enzyme induction and normal-sized red blood cells. Normal values do not rule out alcohol use disorder, however. When values are raised, different connections need to be considered: GGT rises with liver enzyme induction caused by alcohol; AST and ALT rise with cell damage, and an AST value higher than the ALT value, often at a ratio close to two to one, is considered a typical pattern of alcohol-related liver damage. An MCV above 100 is described as a sign of enlarged red blood cells (macrocytosis). Possible causes include direct damage to the bone marrow and folate deficiency, even before anemia develops. Fatigue, reduced stamina, inflammation of the tongue or nerve damage may occur alongside it. In women, enzyme and MCV changes can occur at lower levels of alcohol consumption than in men, and pregnancy typically lowers GGT, while shifts in iron status can lower MCV. When values are low, they usually point to minimal enzyme induction; a particularly low MCV suggests iron deficiency or thalassemia rather than an effect of alcohol. Iron deficiency should be considered especially in menstruating adolescents and women. Over time, GGT, AST/ALT and MCV help put possible effects of alcohol on the liver, bone marrow and metabolism into context. The source links this to estimating risks such as liver cirrhosis, pancreatitis, cardiomyopathy, heart rhythm disorders, cognitive decline and certain cancers. Additional trends in bilirubin, INR, platelets, ferritin, triglycerides and CDT can round out the assessment of physical effects.
What blood tests show about alcohol use and its physical effects
Blood tests for alcohol use disorder (AUD) can capture the effects of sustained drinking on the liver, blood cells and metabolism. Three commonly examined markers are gamma-glutamyl transferase (GGT), aspartate aminotransferase/alanine aminotransferase (AST/ALT) and mean corpuscular volume (MCV). Together, these markers help put the effects of alcohol on the liver, blood and metabolism into context. GGT is an enzyme found in liver cells and is often raised when alcohol puts strain on the liver. AST and ALT are enzymes that help process amino acids; when liver cells are damaged, these enzymes enter the bloodstream and signal liver damage. MCV measures the average size of red blood cells, which can increase with chronic drinking because of alcohol’s effects on the bone marrow and nutrient absorption. The source treats unremarkable results as a favorable sign for the liver, blood cells and metabolism; on their own, however, they do not prove the absence of alcohol use disorder. Raised GGT or AST/ALT values can point to liver stress or liver damage, while a high MCV can point to changes in blood cell production linked to alcohol’s effects on the body. Persistent abnormalities can indicate ongoing physical strain. How these results are interpreted depends on several factors, including age, sex, existing conditions, medications and even recent illnesses. Laboratory methods and reference ranges can also vary, so the results are best understood in the context of a person’s overall health.
Frequently asked questions
What is a blood test for alcohol use disorder?
The test measures markers such as GGT, AST/ALT and MCV to assess possible effects of alcohol on the liver and blood cells. GGT rises with alcohol-induced enzyme induction and cholestasis. AST and ALT reflect hepatocellular damage, meaning damage to liver cells; the AST/ALT ratio helps identify an alcohol-related pattern. MCV measures the size of red blood cells and often rises with sustained heavy drinking because of effects on the bone marrow and folate status. These markers capture physical effects. They cannot diagnose alcohol use disorder on their own.
Why should I get a blood test for alcohol dependence?
A blood test can detect physical strain from alcohol before symptoms become noticeable. Raised GGT and an AST/ALT pattern can point to alcohol-related liver damage; a raised MCV shows bone marrow effects from chronic drinking. Together, these markers help estimate severity, establish a baseline, and track recovery or signs of renewed drinking over time. The results add to the assessment of physical health and indicate whether further liver testing is needed. They complement clinical assessment but do not replace it.
Can I have a blood test done at home?
Depending on what is available in your area, a blood draw at home may be possible. For GGT, AST/ALT and MCV, blood is taken from a vein, just as in a doctor’s office, and analyzed in an accredited laboratory. Repeated measurements can make changes over time visible.
How often should I get tested?
The source suggests yearly testing for general screening. When monitoring progress, the markers change at different speeds: AST/ALT within days to weeks, GGT over 2–3 weeks and MCV over 1–3 months. As possible intervals between checks, it suggests 4–12 weeks at first and then 3–6 months. The right interval depends on the initial findings, the question being asked and how things develop.
What can affect biomarker levels?
Many factors unrelated to drinking can raise or lower these markers. Fatty liver disease, viral hepatitis, bile duct disease, heart failure and thyroid disease can alter enzyme levels. Medications (for example anticonvulsants, acetaminophen (paracetamol), statins and some antibiotics) and smoking can raise GGT. Intense exercise or muscle injury raises AST. B12 or folate deficiency, hypothyroidism and recent transfusions affect MCV. Age, sex, obesity and sample handling also influence results. Context matters.
How do I prepare for a blood test for GGT, AST/ALT and MCV?
Fasting is usually not required. The source recommends avoiding strenuous exercise for 24–48 hours beforehand to prevent temporary rises in AST. Drinking alcohol in the preceding 24–48 hours can affect GGT and AST/ALT; follow the specific instructions from your doctor’s office or laboratory. Stay well hydrated and bring a list of the medications and dietary supplements you take so that possible influences can be taken into account.
Can lifestyle changes affect my biomarker levels?
Yes. A change in drinking can explain many of the shifts observed: AST/ALT can change within days to weeks, GGT typically normalizes within 2–4 weeks, while MCV often improves only within 1–3 months. Diet (B12/folate), body weight, smoking and exercise habits can also influence the values. Trends over time show the physiological effects of these changes.
How do I interpret my results?
What matters is the combination of values and how they change over time. A raised GGT with AST higher than ALT, especially an AST/ALT ratio above 2, suggests an alcohol-related pattern of damage. An isolated rise in GGT is common but nonspecific. A high MCV points to chronic heavy strain or problems with folate or B12. Normal results do not rule out alcohol dependence. The markers and their trends should be assessed together in a conversation with a doctor.
Sources and references
Tavakoli HR, Hull M, Okasinski M (2011). Review of current clinical biomarkers for the detection of alcohol dependence. Innovations in Clinical Neuroscience, 8(3), 26-33. https://pubmed.ncbi.nlm.nih.gov/21487543/ Publication
Stewart SH, Koch DG, Willner IR, Anton RF, Reuben A (2014). Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcoholism: Clinical and Experimental Research, 38(6), 1706-1711. https://doi.org/10.1111/acer.12442 Publication
Niemela O, Parkkila S (2004). Alcoholic macrocytosis: Is there a role for acetaldehyde and adducts? Addiction Biology, 9(1), 3-10. https://doi.org/10.1080/13556210410001674031 Publication
Majhi S, Baral N, Lamsal M, Mehta KD (2006). De Ritis ratio as diagnostic marker of alcoholic liver disease. Nepal Medical College Journal, 8(1), 40-42. https://pubmed.ncbi.nlm.nih.gov/16827089/ Publication
Higgins-Biddle JC, Babor TF (2018). A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. The American Journal of Drug and Alcohol Abuse, 44(6), 578-586. https://doi.org/10.1080/00952990.2018.1456545 Publication